The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis

The performance of the galactomannan enzyme immunoassay (GM-EIA) is impaired in patients receiving mould-active antifungal therapy. The impact of mould-active antifungal therapy on Aspergillus PCR testing needs to be determined.To determine the influence of anti-mould prophylaxis (AMP) on the perfor...

Full description

Saved in:
Bibliographic Details
Main Authors: Cruciani, Mario (Author) , White, P L (Author) , Mengoli, C (Author) , Löffler, J (Author) , Morton, C O (Author) , Klingspor, L (Author) , Buchheidt, Dieter (Author) , Maertens, J (Author) , Heinz, W J (Author) , Rogers, T R (Author) , Weinbergerova, B (Author) , Warris, A (Author) , Lockhart, D E A (Author) , Jones, B (Author) , Cordonnier, C (Author) , Donnelly, J P (Author) , Barnes, R A (Author)
Format: Article (Journal)
Language:English
Published: March 2021
In: The journal of antimicrobial chemotherapy
Year: 2021, Volume: 76, Issue: 3, Pages: 635-638
ISSN:1460-2091
DOI:10.1093/jac/dkaa498
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/jac/dkaa498
Get full text
Author Notes:M. Cruciani, P.L. White, C. Mengoli, J. Löffler, C.O. Morton, L. Klingspor, D. Buchheidt, J. Maertens, W.J. Heinz, T.R. Rogers, B. Weinbergerova, A. Warris, D.E.A Lockhart, B. Jones, C. Cordonnier, J.P Donnelly and R.A Barnes

MARC

LEADER 00000caa a2200000 c 4500
001 1769702946
003 DE-627
005 20220820042049.0
007 cr uuu---uuuuu
008 210908s2021 xx |||||o 00| ||eng c
024 7 |a 10.1093/jac/dkaa498  |2 doi 
035 |a (DE-627)1769702946 
035 |a (DE-599)KXP1769702946 
035 |a (OCoLC)1341421154 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Cruciani, Mario  |e VerfasserIn  |0 (DE-588)1240791720  |0 (DE-627)1769701435  |4 aut 
245 1 4 |a The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis  |c M. Cruciani, P.L. White, C. Mengoli, J. Löffler, C.O. Morton, L. Klingspor, D. Buchheidt, J. Maertens, W.J. Heinz, T.R. Rogers, B. Weinbergerova, A. Warris, D.E.A Lockhart, B. Jones, C. Cordonnier, J.P Donnelly and R.A Barnes 
264 1 |c March 2021 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.09.2021 
520 |a The performance of the galactomannan enzyme immunoassay (GM-EIA) is impaired in patients receiving mould-active antifungal therapy. The impact of mould-active antifungal therapy on Aspergillus PCR testing needs to be determined.To determine the influence of anti-mould prophylaxis (AMP) on the performance of PCR blood testing to aid the diagnosis of proven/probable invasive aspergillosis (IA).As part of the systematic review and meta-analysis of 22 cohort studies investigating Aspergillus PCR blood testing in 2912 patients at risk of IA, subgroup analysis was performed to determine the impact of AMP on the accuracy of Aspergillus PCR. The incidence of IA was calculated in patients receiving and not receiving AMP. The impact of two different positivity thresholds (requiring either a single PCR positive test result or ≥2 consecutive PCR positive test results) on accuracy was evaluated. Meta-analytical pooling of sensitivity and specificity was performed by logistic mixed-model regression.In total, 1661 (57%) patients received prophylaxis. The incidence of IA was 14.2%, significantly lower in the prophylaxis group (11%-12%) compared with the non-prophylaxis group (18%-19%) (P<0.001). The use of AMP did not affect sensitivity, but significantly decreased specificity [single PCR positive result threshold: 26% reduction (P=0.005); ≥2 consecutive PCR positive results threshold: 12% reduction (P=0.019)].Contrary to its influence on GM-EIA, AMP significantly decreases Aspergillus PCR specificity, without affecting sensitivity, possibly as a consequence of AMP limiting the clinical progression of IA and/or leading to false-negative GM-EIA results, preventing the classification of probable IA using the EORTC/MSGERC definitions. 
700 1 |a White, P L  |e VerfasserIn  |4 aut 
700 1 |a Mengoli, C  |e VerfasserIn  |4 aut 
700 1 |a Löffler, J  |e VerfasserIn  |4 aut 
700 1 |a Morton, C O  |e VerfasserIn  |4 aut 
700 1 |a Klingspor, L  |e VerfasserIn  |4 aut 
700 1 |a Buchheidt, Dieter  |d 1955-  |e VerfasserIn  |0 (DE-588)1028287461  |0 (DE-627)730538621  |0 (DE-576)375787380  |4 aut 
700 1 |a Maertens, J  |e VerfasserIn  |4 aut 
700 1 |a Heinz, W J  |e VerfasserIn  |4 aut 
700 1 |a Rogers, T R  |e VerfasserIn  |4 aut 
700 1 |a Weinbergerova, B  |e VerfasserIn  |4 aut 
700 1 |a Warris, A  |e VerfasserIn  |4 aut 
700 1 |a Lockhart, D E A  |e VerfasserIn  |4 aut 
700 1 |a Jones, B  |e VerfasserIn  |4 aut 
700 1 |a Cordonnier, C  |e VerfasserIn  |4 aut 
700 1 |a Donnelly, J P  |e VerfasserIn  |4 aut 
700 1 |a Barnes, R A  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The journal of antimicrobial chemotherapy  |d Oxford : Oxford Univ. Press, 1975  |g 76(2021), 3 vom: März, Seite 635-638  |h Online-Ressource  |w (DE-627)266876838  |w (DE-600)1467478-6  |w (DE-576)075144972  |x 1460-2091  |7 nnas  |a The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis 
773 1 8 |g volume:76  |g year:2021  |g number:3  |g month:03  |g pages:635-638  |g extent:4  |a The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis 
856 4 0 |u https://doi.org/10.1093/jac/dkaa498  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210908 
993 |a Article 
994 |a 2021 
998 |g 1028287461  |a Buchheidt, Dieter  |m 1028287461:Buchheidt, Dieter  |d 60000  |d 61200  |e 60000PB1028287461  |e 61200PB1028287461  |k 0/60000/  |k 1/60000/61200/  |p 7 
999 |a KXP-PPN1769702946  |e 3974878653 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1460-2091"],"eki":["266876838"],"zdb":["1467478-6"]},"origin":[{"publisher":"Oxford Univ. Press","dateIssuedKey":"1975","dateIssuedDisp":"1975-","publisherPlace":"Oxford"}],"name":{"displayForm":["the British Society for Antimicrobial Chemotherapy"]},"titleAlt":[{"title":"JAC"}],"part":{"extent":"4","volume":"76","text":"76(2021), 3 vom: März, Seite 635-638","pages":"635-638","issue":"3","year":"2021"},"pubHistory":["1.1975 -"],"recId":"266876838","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosisThe journal of antimicrobial chemotherapy","note":["Gesehen am 27.10.21"],"title":[{"subtitle":"JAC","title":"The journal of antimicrobial chemotherapy","title_sort":"journal of antimicrobial chemotherapy"}]}],"physDesc":[{"extent":"4 S."}],"id":{"eki":["1769702946"],"doi":["10.1093/jac/dkaa498"]},"origin":[{"dateIssuedDisp":"March 2021","dateIssuedKey":"2021"}],"name":{"displayForm":["M. Cruciani, P.L. White, C. Mengoli, J. Löffler, C.O. Morton, L. Klingspor, D. Buchheidt, J. Maertens, W.J. Heinz, T.R. Rogers, B. Weinbergerova, A. Warris, D.E.A Lockhart, B. Jones, C. Cordonnier, J.P Donnelly and R.A Barnes"]},"language":["eng"],"recId":"1769702946","note":["Gesehen am 08.09.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis","title_sort":"impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Cruciani, Mario","given":"Mario","family":"Cruciani"},{"roleDisplay":"VerfasserIn","display":"White, P L","role":"aut","family":"White","given":"P L"},{"role":"aut","display":"Mengoli, C","roleDisplay":"VerfasserIn","given":"C","family":"Mengoli"},{"given":"J","family":"Löffler","role":"aut","display":"Löffler, J","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Morton, C O","given":"C O","family":"Morton"},{"family":"Klingspor","given":"L","roleDisplay":"VerfasserIn","display":"Klingspor, L","role":"aut"},{"role":"aut","display":"Buchheidt, Dieter","roleDisplay":"VerfasserIn","given":"Dieter","family":"Buchheidt"},{"display":"Maertens, J","roleDisplay":"VerfasserIn","role":"aut","family":"Maertens","given":"J"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Heinz, W J","given":"W J","family":"Heinz"},{"family":"Rogers","given":"T R","roleDisplay":"VerfasserIn","display":"Rogers, T R","role":"aut"},{"family":"Weinbergerova","given":"B","roleDisplay":"VerfasserIn","display":"Weinbergerova, B","role":"aut"},{"given":"A","family":"Warris","role":"aut","display":"Warris, A","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Lockhart, D E A","given":"D E A","family":"Lockhart"},{"display":"Jones, B","roleDisplay":"VerfasserIn","role":"aut","family":"Jones","given":"B"},{"display":"Cordonnier, C","roleDisplay":"VerfasserIn","role":"aut","family":"Cordonnier","given":"C"},{"family":"Donnelly","given":"J P","display":"Donnelly, J P","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Barnes","given":"R A","display":"Barnes, R A","roleDisplay":"VerfasserIn","role":"aut"}]} 
SRT |a CRUCIANIMAIMPACTOFAN2021